749 A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIA clinical trial
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S277-S278
- https://doi.org/10.1016/s0168-8278(06)80750-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: